Medicines losing patent protection

MonthYear

February 2026

3 medicines lost their last listed patent or exclusivity in February 2026.

Feb 13Egatentriclabendazole · Novartis Pharmaceuticals Corp
Feb 21Briviact · Solution (intravenous)brivaracetam · UCB Inc
Feb 21Briviact · Solution (oral)brivaracetam · UCB Inc

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits